PCOS DIAGNOSTIC MARKET ANALYSIS

Market Challenges And Opportunities

PCOS diagnostic Market Drivers:

• Increasing Prevalence of PCOS: PCOS is a common hormonal disorder, affecting a significant number of women worldwide. The increasing prevalence of PCOS is one of the primary drivers of the global PCOS diagnostic market. According to various studies, the prevalence of PCOS ranges from 5% to 20% globally.
• Growing Awareness and Early Diagnosis: There is a growing awareness among healthcare professionals and patients about PCOS and its potential health risks. Early diagnosis of PCOS is crucial for effective management and prevention of associated complications, such as infertility, metabolic disorders, and cardiovascular This awareness drives the demand for PCOS diagnostic tests.
• Technological Advancements in Diagnostics: Advances in diagnostic technologies, such as ultrasound, hormonal assays, and genetic testing, have improved the accuracy and efficiency of PCOS diagnosis. These technological advancements enable healthcare providers to diagnose PCOS more effectively and contribute to the growth of the PCOS diagnostic market.
• Rising Healthcare Expenditure: Increasing healthcare expenditure, particularly in developing countries, supports the expansion of the PCOS diagnostic market. As healthcare infrastructure improves and access to healthcare services expands, more individuals have the opportunity to undergo PCOS diagnostic tests, driving market growth.

Recent Developments

New product launches

• In October 2022, Veera Health, one of the largest digital therapeutic platforms for managing polycystic ovary syndrome (PCOS), recently launched a comprehensive test for diagnosing PCOS. The diagnostic packages are currently available in 24 Indian cities including Agra, Allahabad, Bangalore, Bhubaneswar, Chandigarh, Chennai, Faridabad, Ghaziabad, Gurgaon, Howrah WB, Hyderabad, Jaipur, Kanpur, Kolkata, Lucknow, Meerut, Mumbai, New Delhi, Noida, Patna, Pune, Ranchi, Surat, and Varanasi.
• In November 2021, Allara Health Inc., a provider of diagnostic test kits, announced the launch of its diagnostic test for polycystic ovary syndrome (PCOS), to overcome the huge demand for PCOS diagnostic
• In 2021, Arogya Meditech, a biotechnology company, launched "PCOScan," a diagnostic test designed specifically for PCOS. PCOScan is a comprehensive blood-based test that measures multiple hormonal parameters and provides an assessment of PCOS risk. It aims to provide an accurate and convenient diagnostic tool for healthcare providers and patients.
• In 2020, Hoffmann-La Roche Ltd., a pharmaceutical company, launched the Elecsys Anti-Müllerian Hormone (AMH) immunoassay, a test that measures AMH levels in blood samples. AMH is a hormone that plays a role in ovarian function and can be used as a marker for PCOS diagnosis and assessment of ovarian reserve.

Acquisition and partnerships

• On July 6, 2023, Proov, a company that developed an at-home PdG test that measures the presence of progesterone metabolite PdG in urine, announced a collaboration with Quest Diagnostics, a company that provides diagnostic test kits for PCOS to access the Proov Confirm PdG home collection kit for assessing fertility through questhealth.com.
• On June 27, 2023, Thriva Ltd, a company offering health tests, announced partnership with Superdrug, a company that provides online health test kits to help people spot the warning signs of disease and positively change their behaviors.
• Thermo Fisher Scientific Acquires Mesa Biotech (February 2021): Thermo Fisher Scientific, a leading life sciences company, acquired Mesa Biotech, a molecular diagnostic company. This acquisition aimed to strengthen Thermo Fisher's position in the point-of-care molecular diagnostics market, including the PCOS diagnostic segment.
• Quest Diagnostics and Let's Get Checked Partnership (2021): Quest Diagnostics, one of the largest diagnostic testing providers, partnered with Let's Get Checked, a direct-to-consumer testing company. This partnership allowed Quest Diagnostics to expand its reach in the consumer market and offer at-home PCOS diagnostic testing options through Let's Get Checked's platform.